{
  "openalex_id": "W2075757227",
  "doi": "https://doi.org/10.7326/acpjc-2015-162-8-003",
  "title": "Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants",
  "abstract": "ACP Journal Club21 April 2015Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulantsChristine M. Ribic, MD, MSc, FRCPC, Catherine M. Clase, MB, BChir, MSc, FRCPCChristine M. Ribic, MD, MSc, FRCPCMcMaster University, Hamilton, Ontario, Canada (C.M.R., C.M.C.)Search for more papers by this author, Catherine M. Clase, MB, BChir, MSc, FRCPCMcMaster University, Hamilton, Ontario, Canada (C.M.R., C.M.C.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2015-162-8-003 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationPathak R, Pandit A, Karmacharya P, et al. Meta-analysis on risk of bleeding with apixaban in patients with renal impairment. Am J Cardiol. 2015;115:323-7. https://pubmed.ncbi.nlm.nih.gov/25527282Clinical Impact RatingsGIM/FP/GP: Cardiology: Hematology: Nephrology: References1. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51. [PMID: 19717844] Google Scholar2. Hernandez I, Baik SH, Piñera A, Zhang Y. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern Med. 2015;175:18-24. [PMID: 25365537] Google Scholar3. Jun M, James MT, Manns BJ, et al; Alberta Kidney Disease Network. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ. 2015;350:h246. [PMID: 25647223] Google Scholar4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3:1−150. Google Scholar Author, Article, and Disclosure InformationAffiliations: McMaster University, Hamilton, Ontario, Canada (C.M.R., C.M.C.)This article was published at Annals.org on 7 April 2015. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByClinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis 21 April 2015Volume 162, Issue 8Page: JC3KeywordsAcute renal failureAnticoagulantsCreatinineDrugsHemorrhageKidneysResearch designSafety ePublished: 21 April 2015 Issue Published: 21 April 2015 CopyrightCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...",
  "authors": [
    {
      "display_name": "Christine Ribic",
      "id": "A5075397073",
      "orcid": null,
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Christine M. Ribic"
    },
    {
      "display_name": "Catherine M. Clase",
      "id": "A5089183562",
      "orcid": "https://orcid.org/0000-0002-4538-5958",
      "institutions": [
        {
          "id": "I98251732",
          "display_name": "McMaster University",
          "country_code": "CA",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Catherine M. Clase"
    }
  ],
  "publication_year": 2015,
  "publication_date": "2015-04-01",
  "type": "letter",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S119722071",
    "display_name": "Annals of Internal Medicine",
    "issn_l": "0003-4819",
    "issn": [
      "0003-4819",
      "1539-3704"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310316812"
  },
  "volume": "162",
  "issue": "8",
  "first_page": "JC3",
  "last_page": "JC3",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2780638905",
      "display_name": "Apixaban",
      "level": 5,
      "score": 0.9215433
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.9134784
    },
    {
      "id": "C2778810321",
      "display_name": "Dabigatran",
      "level": 4,
      "score": 0.8111863
    },
    {
      "id": "C2779161974",
      "display_name": "Atrial fibrillation",
      "level": 2,
      "score": 0.7720968
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.6985843
    },
    {
      "id": "C2776301958",
      "display_name": "Warfarin",
      "level": 3,
      "score": 0.60497934
    },
    {
      "id": "C2778653478",
      "display_name": "Kidney disease",
      "level": 2,
      "score": 0.6039521
    },
    {
      "id": "C164705383",
      "display_name": "Cardiology",
      "level": 1,
      "score": 0.5251874
    },
    {
      "id": "C159641895",
      "display_name": "Renal function",
      "level": 2,
      "score": 0.46946064
    },
    {
      "id": "C2780645631",
      "display_name": "Stroke (engine)",
      "level": 2,
      "score": 0.4573895
    },
    {
      "id": "C54847362",
      "display_name": "Nephrology",
      "level": 2,
      "score": 0.45729387
    },
    {
      "id": "C23131810",
      "display_name": "Observational study",
      "level": 2,
      "score": 0.44891295
    },
    {
      "id": "C2778661090",
      "display_name": "Rivaroxaban",
      "level": 4,
      "score": 0.43929935
    },
    {
      "id": "C2908647359",
      "display_name": "Population",
      "level": 2,
      "score": 0.4296701
    },
    {
      "id": "C78519656",
      "display_name": "Mechanical engineering",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C99454951",
      "display_name": "Environmental health",
      "level": 1,
      "score": 0.0
    },
    {
      "id": "C127413603",
      "display_name": "Engineering",
      "level": 0,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T10065",
      "display_name": "Atrial Fibrillation Management and Outcomes",
      "score": 0.9778
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.7326/acpjc-2015-162-8-003",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T14:28:04.516455",
  "source_database": "OpenAlex"
}